about
Need for improved monitoring in patients with acromegalyResults of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenomaSafety and tolerability of pasireotide long-acting release in acromegaly-results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Drug insight: Primary medical therapy of acromegaly.
@ast
Drug insight: Primary medical therapy of acromegaly.
@en
type
label
Drug insight: Primary medical therapy of acromegaly.
@ast
Drug insight: Primary medical therapy of acromegaly.
@en
prefLabel
Drug insight: Primary medical therapy of acromegaly.
@ast
Drug insight: Primary medical therapy of acromegaly.
@en
P2860
P356
P1476
Drug insight: Primary medical therapy of acromegaly.
@en
P2093
Laurence Katznelson
P2860
P2888
P304
109-17; quiz following 117
P356
10.1038/NCPENDMET0096
P577
2006-02-01T00:00:00Z
P6179
1040500353